Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-29 21:28:46 - browse：161

inflamed intestine on a dark blue background — biotech coverage from STAT — Adobe

What happens after you close a nearly $11 billion acquisition?

Well, for Prometheus Therapeutics’ former CEO Mark McKenna, there was a brief vacation. But within weeks of the company’s acquisition by Merck closing last June, he was thinking about ideas for the future.

Investors were floating ideas by him. McKenna discussed possibilities with his teenagers and Prometheus’ chief scientific officer. This “summer of discovery,” as McKenna called it, brought him back to the immune system. Prometheus and some other companies have been able to capitalize on creating treatments for conditions like inflammatory bowel disease and psoriasis, while arthritis medications like Humira have brought in billions of dollars in sales. But the field hadn’t quite received the same attention as missions to cure cancer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Will General Catalyst be the first of many hospital takeovers?

hotspot

WSS

FDA approves potent Eli Lilly obesity drug, Zepbound

Free speech concerns arise in wake of journal editor Eisen's firing

Why more medical students aren't specializing in primary care

Biotech incubator Curie.Bio graduates its first startup

Australia’s approach to dialysis celebrates life

FDA approves Recor Medical high blood pressure device

entertainment

Wikipedia

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

Apellis safety probe of eye disease drug centers on injection needle

How one medical school became remarkably diverse

MoonLake credibility takes another hit with mid

How to save PrEP access — and even expand it

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Virginia high school admissions case could be legal follow

Apellis safety probe of eye disease drug centers on injection needle

How to save PrEP access — and even expand it

10 million people disenrolled from Medicaid over past six months

focus

What AAP's gender

MoonLake credibility takes another hit with mid

Medicare explains how it will choose drugs for negotiation

Sanofi CEO defends move to abandon profit guidance, boost research

FDA approves potent Eli Lilly obesity drug, Zepbound

Removing probiotics from the NICU could threaten preemies' health

hotspot

hotspot

entertainment

Wikipedia